Press release
Investigation announced for Investors in Protagonist Therapeutics, Inc. (NASDAQ: PTGX) over potential Wrongdoing
An investigation on behalf of investors in Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares over potential wrongdoing.
Investors who purchased shares of Protagonist Therapeutics, Inc. (NASDAQ: PTGX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Protagonist Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
Newark, CA based Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. On April 13, 2022, Protagonist disclosed in a filing with the U.S. Securities and Exchange Commission that "[t]he Company has received a letter from United States Food and Drug Administration (the "FDA") indicating the FDA's intent to rescind Breakthrough Therapy Designation for the Company's rusfertide product candidate in polycythemia vera," citing "observed malignancies[.]"
Shares of Protagonist Therapeutics, Inc. (NASDAQ: PTGX) declined from $38.11 per share on November 15, 2011, to as low as $7.49 per share on May 18, 2022.
Those who purchased shares of Protagonist Therapeutics, Inc. (NASDAQ: PTGX) have certain options and should contact the Shareholders Foundation.
Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in Protagonist Therapeutics, Inc. (NASDAQ: PTGX) over potential Wrongdoing here
News-ID: 2659806 • Views: …
More Releases from Shareholders Foundation
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…
More Releases for Protagonist
Mumbai Hosts Powerful Premiere of The Protagonist Show and Launch of Sheroes Amo …
In a stirring evening of storytelling, empowerment, and emotion, The Protagonist Show premiered alongside the launch of the book Sheroes Amongst Us - Real Women Real Stories at an exclusive event on June 21. Held in Mumbai, the event was powered by Etherwire.ai, a Multiplaylist Platform, and F13 Happenings.
Co-authored by Falguni Desai and Dr. Amit Nagpal, the book highlights real-life stories of women who transformed adversity into strength, inspiring audiences…
Polycythemia Vera Drugs Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Polycythemia Vera Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Polycythemia Vera, historical and forecasted epidemiology as well as the Polycythemia Vera market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom, and Japan.
Discover which therapies are expected to grab the Polycythemia Vera Market Share @ Polycythemia Vera Market Outlook- https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Polycythemia Vera Market Report
• In…
Polycythemia Vera Market to Show Remarkable Growth Trends from 2024 to 2034, Del …
DelveInsight's "Polycythemia Vera Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Polycythemia Vera, historical and forecasted epidemiology as well as the Polycythemia Vera market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Polycythemia Vera market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Polycythemia Vera Market Forecast
https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Polycythemia Vera Market Predicted to See Upsurge Through 2034, Highlights Delve …
DelveInsight's "Polycythemia Vera Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Polycythemia Vera, historical and forecasted epidemiology as well as the Polycythemia Vera market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Polycythemia Vera market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Polycythemia Vera Market Forecast
https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Polycythemia Vera Market to Observe Impressive Growth During the Forecast Period …
DelveInsight's "Polycythemia Vera Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Polycythemia Vera, historical and forecasted epidemiology as well as the Polycythemia Vera market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Polycythemia Vera market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Polycythemia Vera Market Forecast
https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Hereditary Hemochromatosis (HH) Market to Witness Growth by 2032, Estimates Delv …
DelveInsight's "Hereditary Hemochromatosis (HH) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hereditary Hemochromatosis (HH), historical and forecasted epidemiology as well as the Hereditary Hemochromatosis (HH) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Hereditary Hemochromatosis (HH) market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted…
